Earnings · China A-shares
Beijing Aosaikang Pharmaceutical Co., Ltd. Class A (002755) earnings
Beijing Aosaikang Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-28: net profit -24.14% year on year, -21.26% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -2.70% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- -24.14%
- Excl. one-offs YoY
- -21.26%
- Net profit QoQ
- +34.84%
- Result
- Bad / loss
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -3.68% | — |
| 3 days | -2.70% | — |
| 7 days | +3.43% | — |
| 14 days | -1.96% | — |
Report history
Over the last 8 reports, net profit grew year on year in 6 of them. The stock rose in the 3 trading days after 3 of 6 reports (average +0.87%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | ¥169.40M | -24.14% | -21.26% | -12.99% | 0.18 | 5.22% | -2.70% | — | — |
| 2026 interim report | 2026-08-28 | ¥120.63M | -24.60% | -24.44% | -13.54% | 0.13 | 3.81% | -4.87% | +1.52% | +11.21% |
| 2026 Q1 report | 2026-04-29 | ¥84.47M | +54.34% | +74.80% | -5.26% | 0.09 | 2.59% | +9.64% | -13.77% | -14.72% |
| 2025 annual report | 2026-04-29 | ¥236.60M | +47.60% | +55.75% | +0.08% | 0.25 | 7.52% | +9.64% | -13.77% | -14.72% |
| 2025 Q3 report | 2025-10-29 | ¥223.31M | +75.81% | +81.89% | +3.57% | 0.24 | 7.13% | +3.12% | -9.38% | -5.90% |
| 2025 interim report | 2025-08-29 | ¥159.99M | +111.64% | +155.68% | +9.20% | 0.17 | 5.07% | -1.35% | -17.67% | -18.95% |
| 2025 Q1 report | 2025-04-28 | ¥54.73M | +73.50% | +86.93% | +13.39% | 0.06 | 1.76% | +1.35% | +2.64% | -0.60% |
| 2024 annual report | 2025-04-28 | ¥160.29M | +207.92% | +155.50% | +23.15% | 0.17 | 5.38% | +1.35% | +2.64% | -0.60% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.